10-K Filing

CVS HEALTH CORP CIK: 64803 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001558370-18-000707`
Period End Date	20171231
Filing Date	20180214
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	cvs-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 154 Cash Flow Statement 128 Stockholders Equity 16 Comprehensive Income 24

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.48B	USD	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.46B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.37B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$111.00M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$87.00M	USD	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$13.18B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$12.16B	USD	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$14.76B	USD	Point-in-time
Inventories	`InventoryNet`	$15.30B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$945.00M	USD	Point-in-time
Common Stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common Stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$660.00M	USD	Point-in-time
Common Stock, shares issued (in shares)	`CommonStockSharesIssued`	1.71B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$31.04B	USD	Point-in-time
Common Stock, shares issued (in shares)	`CommonStockSharesIssued`	1.71B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$31.23B	USD	Point-in-time
Common Stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.01B	shares	Point-in-time
Common Stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.06B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.29B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.18B	USD	Point-in-time
Treasury Stock, shares (in shares)	`TreasuryStockShares`	643.00M	shares	Point-in-time
Goodwill	`Goodwill`	$38.11B	USD	Point-in-time
Treasury Stock, shares (in shares)	`TreasuryStockShares`	697.00M	shares	Point-in-time
Goodwill	`Goodwill`	$38.25B	USD	Point-in-time
Goodwill	`Goodwill`	$38.45B	USD	Point-in-time
Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares)	`CommonStockSharesHeldInEmployeeTrustShares`	1.00M	shares	Point-in-time
Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares)	`CommonStockSharesHeldInEmployeeTrustShares`	1.00M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.63B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.51B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.53B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.49B	USD	Point-in-time
Total assets	`Assets`	$95.13B	USD	Point-in-time
Total assets	`Assets`	$94.46B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.95B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.86B	USD	Point-in-time
Claims and discounts payable	`ClaimsAndDiscountsPayable`	$9.45B	USD	Point-in-time
Claims and discounts payable	`ClaimsAndDiscountsPayable`	$10.36B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.94B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.61B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.28B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.87B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$42.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.54B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.25B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.65B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$22.18B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$25.61B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$3.00B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$4.21B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.55B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.61B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 and 1,705 shares issued and 1,061 shares outstanding at December 31, 2016	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 and 1,705 shares issued and 1,061 shares outstanding at December 31, 2016	`CommonStockValue`	$17.00M	USD	Point-in-time
Treasury stock, at cost: 697 shares at December 31, 2017 and 643 shares at December 31, 2016	`TreasuryStockValue`	$37.77B	USD	Point-in-time
Treasury stock, at cost: 697 shares at December 31, 2017 and 643 shares at December 31, 2016	`TreasuryStockValue`	$33.45B	USD	Point-in-time
Shares held in trust: 1 share at December 31, 2017 and December 31, 2016	`CommonStockSharesHeldInEmployeeTrust`	$31.00M	USD	Point-in-time
Shares held in trust: 1 share at December 31, 2017 and December 31, 2016	`CommonStockSharesHeldInEmployeeTrust`	$31.00M	USD	Point-in-time
Capital surplus	`AdditionalPaidInCapital`	$31.62B	USD	Point-in-time
Capital surplus	`AdditionalPaidInCapital`	$32.08B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$38.98B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$43.56B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-305.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-165.00M	USD	Point-in-time
Total CVS Health shareholders' equity	`StockholdersEquity`	$37.69B	USD	Point-in-time
Total CVS Health shareholders' equity	`StockholdersEquity`	$36.83B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.83B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.20B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$95.13B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$94.46B	USD	Point-in-time

Income Statement 154 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$43.22B	USD	1 Quarter
Net revenues	`Revenues`	$43.73B	USD	1 Quarter
Net revenues	`Revenues`	$46.18B	USD	1 Quarter
Net revenues	`Revenues`	$44.62B	USD	1 Quarter
Net revenues	`Revenues`	$184.76B	USD	Annual
Net revenues	`Revenues`	$44.51B	USD	1 Quarter
Net revenues	`Revenues`	$45.69B	USD	1 Quarter
Net revenues	`Revenues`	$153.29B	USD	Annual
Net revenues	`Revenues`	$48.38B	USD	1 Quarter
Net revenues	`Revenues`	$177.53B	USD	Annual
Net revenues	`Revenues`	$45.97B	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$126.76B	USD	Annual
Cost of revenues	`CostOfRevenue`	$148.67B	USD	Annual
Cost of revenues	`CostOfRevenue`	$156.22B	USD	Annual
Gross profit	`GrossProfit`	$6.93B	USD	1 Quarter
Gross profit	`GrossProfit`	$7.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$6.74B	USD	1 Quarter
Gross profit	`GrossProfit`	$28.55B	USD	Annual
Gross profit	`GrossProfit`	$7.13B	USD	1 Quarter
Gross profit	`GrossProfit`	$6.58B	USD	1 Quarter
Gross profit	`GrossProfit`	$26.53B	USD	Annual
Gross profit	`GrossProfit`	$28.86B	USD	Annual
Gross profit	`GrossProfit`	$7.90B	USD	1 Quarter
Gross profit	`GrossProfit`	$7.61B	USD	1 Quarter
Gross profit	`GrossProfit`	$7.49B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$19.03B	USD	Annual
Operating expenses	`OperatingExpenses`	$17.05B	USD	Annual
Operating expenses	`OperatingExpenses`	$18.49B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$10.37B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$1.79B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$3.00B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$3.11B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$9.47B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$2.19B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$2.36B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$2.12B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$2.82B	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$9.52B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$2.50B	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.04B	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-838.00M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-1.06B	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-643.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Other expense	`OtherNonoperatingExpense`	$28.00M	USD	Annual
Other expense	`OtherNonoperatingExpense`	$208.00M	USD	Annual
Other expense	`OtherNonoperatingExpense`	$21.00M	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.64B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.27B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.62B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$3.32B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$3.39B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$1.64B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$962.00M	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.71B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.28B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.32B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$924.00M	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.23B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.63B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$3.29B	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$9.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-8.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.00M	USD	1 Quarter
Net income	`ProfitLoss`	$5.32B	USD	Annual
Net income	`ProfitLoss`	$5.24B	USD	Annual
Net income	`ProfitLoss`	$6.62B	USD	Annual
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	Annual
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$1.54B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.71B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.15B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$952.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.28B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.10B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$5.32B	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$3.29B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$5.24B	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$6.62B	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$924.00M	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.60	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$6.48	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.93	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.93	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.04	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.07	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.86	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.65	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.23	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.26	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.44	USD	1 Quarter
Income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	Annual
Income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.01	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.04	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.60	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$4.66	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.07	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$3.23	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.26	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$6.47	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$0.92	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.44	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$4.93	USD	Annual
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	Annual
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.12B	shares	Annual
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.07B	shares	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.26	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.86	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.59	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.04	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.43	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$6.45	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.92	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.91	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.22	USD	1 Quarter
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.62	USD	Annual
Income from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.07	USD	1 Quarter
income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	Annual
income (loss) from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.01	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.59	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.26	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.07	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$0.92	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.04	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.43	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$3.22	USD	1 Quarter
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$4.63	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$4.90	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$6.44	USD	Annual
Net income attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	Annual
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.08B	shares	Annual
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.13B	shares	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.40	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.70	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter

Cash Flow Statement 128 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$172.31B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$148.95B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$176.59B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsToSuppliers`	$122.50B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsToSuppliers`	$149.28B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsToSuppliers`	$142.51B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.04B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$15.48B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$15.35B	USD	Annual
Interest received	`ProceedsFromInterestReceived`	$20.00M	USD	Annual
Interest received	`ProceedsFromInterestReceived`	$21.00M	USD	Annual
Interest received	`ProceedsFromInterestReceived`	$21.00M	USD	Annual
Interest paid	`InterestPaidNet`	$1.07B	USD	Annual
Interest paid	`InterestPaidNet`	$629.00M	USD	Annual
Interest paid	`InterestPaidNet`	$1.14B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$3.27B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$3.06B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$2.91B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.01B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.14B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.54B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.37B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.92B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.22B	USD	Annual
Proceeds from sale-leaseback transactions	`SaleLeasebackTransactionNetProceedsInvestingActivities`	$411.00M	USD	Annual
Proceeds from sale-leaseback transactions	`SaleLeasebackTransactionNetProceedsInvestingActivities`	$230.00M	USD	Annual
Proceeds from sale-leaseback transactions	`SaleLeasebackTransactionNetProceedsInvestingActivities`	$265.00M	USD	Annual
Proceeds from sale of property and equipment and other assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$35.00M	USD	Annual
Proceeds from sale of property and equipment and other assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$37.00M	USD	Annual
Proceeds from sale of property and equipment and other assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$33.00M	USD	Annual
Acquisitions (net of cash acquired) and other investments	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$539.00M	USD	Annual
Acquisitions (net of cash acquired) and other investments	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.29B	USD	Annual
Acquisitions (net of cash acquired) and other investments	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.47B	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireShortTermInvestments`	$267.00M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireShortTermInvestments`	$65.00M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireShortTermInvestments`	$86.00M	USD	Annual
Maturity of available-for-sale investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$243.00M	USD	Annual
Maturity of available-for-sale investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$91.00M	USD	Annual
Maturity of available-for-sale investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$61.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.42B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.93B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.47B	USD	Annual
Increase (decrease) in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-598.00M	USD	Annual
Increase (decrease) in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-685.00M	USD	Annual
Increase (decrease) in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$1.87B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.46B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$14.80B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.90B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$5.94B	USD	Annual
Purchase of noncontrolling interest in subsidiary	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$39.00M	USD	Annual
Payment of contingent consideration	`BusinessAcquisitionContingentConsiderationArrangementPaymentMadetoSellerforTaxSavingsonNetOperatingLossAssumed`	$58.00M	USD	Annual
Payment of contingent consideration	`BusinessAcquisitionContingentConsiderationArrangementPaymentMadetoSellerforTaxSavingsonNetOperatingLossAssumed`	$26.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$1.84B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.05B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$1.58B	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$296.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$329.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$362.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$63.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$72.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$71.00M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$4.46B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$4.36B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$5.00B	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.88B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.76B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.75B	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-20.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-22.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.68B	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$912.00M	USD	Annual
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.48B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.46B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.37B	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.48B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.46B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.37B	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Net income	`ProfitLoss`	$5.32B	USD	Annual
Net income	`ProfitLoss`	$5.24B	USD	Annual
Net income	`ProfitLoss`	$6.62B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.48B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.48B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.09B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$181.00M	USD	Annual
Losses on settlement of defined benefit pension plans	`DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1`	$-187.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$230.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$222.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$234.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-643.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-18.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$1.33B	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$252.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$14.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-135.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-53.00M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$941.00M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$243.00M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.59B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$742.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$514.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.14B	USD	Annual
Other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$341.00M	USD	Annual
Other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-355.00M	USD	Annual
Other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-35.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$43.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.00M	USD	Annual
Accounts payable and claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.19B	USD	Annual
Accounts payable and claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.83B	USD	Annual
Accounts payable and claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.71B	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-371.00M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$131.00M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$892.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$38.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-104.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.01B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.14B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.54B	USD	Annual

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Stock options exercised and issuance of stock awards	`StockIssuedDuringPeriodSharesStockOptionsExercised`	4.81M	shares	Annual
Beginning of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Beginning of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.83B	USD	Point-in-time
Beginning of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.20B	USD	Point-in-time
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$38.00M	USD	Annual
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	Annual
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-100.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-10.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$2.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$2.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-13.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$43.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-152.00M	USD	Annual
End of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
End of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.83B	USD	Point-in-time
End of year	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.20B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$5.32B	USD	Annual
Net income	`ProfitLoss`	$5.24B	USD	Annual
Net income	`ProfitLoss`	$6.62B	USD	Annual
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$38.00M	USD	Annual
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	Annual
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-100.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-10.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$2.00M	USD	Annual
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$2.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-13.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$43.00M	USD	Annual
Pension and other postretirement benefits, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-152.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$140.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-141.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$53.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.37B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.76B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.10B	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$2.00M	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$2.00M	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$6.76B	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.10B	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.37B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.